Utilizing the Michigan Neuropathy Screening Instrument, Routine Nerve Conduction Study (NCS), and Nerve Ultrasound for Early Detection of Diabetic Neuropathy

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 33
Maximum Age: 65
View:

• ü Age: 30-55 y

⁃ ü Type of diabetes: Type 2

⁃ ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria

Locations
Other Locations
Egypt
Faculty of medecine Sohag university
RECRUITING
Sohag
Contact Information
Primary
Reda Khalaf Allah Khalil, Resident
redakhalaf@med.sohag.edu.eg
0102 006 5913
Time Frame
Start Date: 2023-06-01
Estimated Completion Date: 2025-06-01
Participants
Target number of participants: 100
Treatments
Patients Group
Study Population:~Place of study: Participants will be recruited from the diabetes clinic, Sohag university hospital.~Type of the study: Cross-Sectional Comparative study.~Patients:~v Study group: participants of the study will meet the following criteria:~Ø Inclusion criteria:~ü Age: 30-55 y~ü Type of diabetes: Type 2~ü Duration of diabetes: Within 1 Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria~ü Gender: Both males \& females~Ø Exclusion criteria:~Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.
Sponsors
Leads: Sohag University

This content was sourced from clinicaltrials.gov